Regn7508

4 trials 1 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

13 Countries

Phase III

Phase II

Phase III: 3 Phase II: 1

Sponsors using this IMP

Regeneron Pharmaceuticals Inc. 4

All trials

4 total

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
REGN7508 versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis after Total Knee Arthroplasty in Adult Participants Pending

2025-520479-25-00 Phase III 2 countries Regeneron Pharmaceuticals Inc.
REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting

2025-520478-20-00 Phase III 6 countries Regeneron Pharmaceuticals Inc.
A trial to learn how well REGN7508 works for preventing blood clots after a knee replacement in adult participants Ended

2023-508602-14-00 Phase II 5 countries Regeneron Pharmaceuticals Inc.

Showing 1–4 of 4 trials

← All drugs A–Z